Cardiotrack, a leading provider of data-centric healthcare screening technology and services, has announced the successful closure of a pre-series A funding round, securing a substantial $2 million investment. This funding round was led by Girish Narasimhan, with co-investment from Y S Shashidhar, signaling a strong vote of confidence in the company’s innovative approach to healthcare delivery.
Founded by Avin Agarwal, Cardiotrack has emerged as a trailblazer in the field, offering cutting-edge pathology and radiology screening services tailored specifically for health and life insurance providers. With a focus on leveraging technology to enhance accessibility and convenience, Cardiotrack has quickly gained traction in the market, attracting significant interest from investors and stakeholders alike.
The recent funding injection builds upon an earlier angel investment of $1.6 million, underscoring the growing momentum behind Cardiotrack’s mission to revolutionize healthcare delivery in India and beyond. As the company sets its sights on expansion and innovation, the infusion of fresh capital is expected to fuel its growth trajectory and position it as a formidable player in the evolving healthcare landscape.
Avin Agarwal, Founder of Cardiotrack, expressed his excitement about the latest funding round, highlighting the company’s commitment to driving positive change in the healthcare industry. He remarked, “We are thrilled to have secured this significant investment, which will enable us to further scale our operations and continue delivering innovative solutions that empower individuals to take control of their health.”
Cardiotrack’s unique value proposition lies in its ability to deliver at-home pathology and radiology screening services, leveraging a vast network of diagnostic centers, technicians, and phlebotomists spanning over 300 locations across India. By harnessing the power of technology, Cardiotrack aims to democratize healthcare access, enabling individuals to undergo critical screenings in the comfort of their own homes.
At the heart of Cardiotrack’s offerings are its advanced screening technologies, which replicate the experience of a traditional treadmill test through a user-friendly, video-based interface. Coupled with medical-grade diagnostics devices and workflow automation solutions, Cardiotrack empowers health and life insurance providers to streamline their onboarding processes and deliver personalized, data-driven care to their customers.
Headquartered in Bengaluru, Cardiotrack is at the forefront of a rapidly evolving healthcare landscape, where digital innovation and data-driven insights are reshaping the way healthcare services are delivered and consumed. With a growing roster of clients that includes nine prominent health and life insurance companies in India, Cardiotrack has established itself as a trusted partner in the quest for better health outcomes.
The infusion of $2 million in funding comes at a pivotal moment for Cardiotrack, as the company looks to expand its reach, enhance its technological capabilities, and capitalize on emerging opportunities in the healthcare market. With a strong track record of innovation and a relentless focus on customer-centric solutions, Cardiotrack is well-positioned to drive positive transformation in the industry.
Girish Narasimhan, Lead Investor in the pre-series A funding round, expressed his confidence in Cardiotrack’s potential to make a meaningful impact in the healthcare sector. He commented, “We believe that Cardiotrack has the vision, expertise, and technology to revolutionize healthcare delivery and improve health outcomes for millions of individuals across India. We are excited to partner with them on this journey.”
As Cardiotrack embarks on the next phase of its growth trajectory, the company remains steadfast in its commitment to innovation, collaboration, and excellence. With a clear focus on leveraging technology to address the evolving needs of the healthcare industry, Cardiotrack is poised to redefine the future of healthcare delivery, one breakthrough at a time.
